MED15
Basic information
Region (hg38): 22:20495913-20587632
Previous symbols: [ "TNRC7", "PCQAP" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MED15 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 44 | 47 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 2 | |||||
Total | 0 | 0 | 45 | 7 | 4 |
Variants in MED15
This is a list of pathogenic ClinVar variants found in the MED15 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-20507691-G-C | not specified | Uncertain significance (Mar 19, 2024) | ||
22-20537211-C-CCCTA | Benign (Apr 12, 2018) | |||
22-20551451-C-G | not specified | Uncertain significance (Dec 15, 2023) | ||
22-20553168-G-A | not specified | Uncertain significance (Aug 15, 2024) | ||
22-20554945-A-G | not specified | Uncertain significance (Apr 23, 2024) | ||
22-20554959-C-G | not specified | Uncertain significance (Aug 12, 2021) | ||
22-20554986-G-A | not specified | Uncertain significance (Jan 24, 2025) | ||
22-20554998-A-T | not specified | Uncertain significance (Jul 06, 2021) | ||
22-20555013-C-G | not specified | Uncertain significance (Jun 04, 2024) | ||
22-20555028-G-A | not specified | Uncertain significance (May 31, 2023) | ||
22-20555029-G-A | not specified | Uncertain significance (May 27, 2022) | ||
22-20555042-C-G | not specified | Uncertain significance (Sep 01, 2021) | ||
22-20555052-A-G | not specified | Uncertain significance (Dec 08, 2023) | ||
22-20555054-G-A | not specified | Uncertain significance (Jan 16, 2024) | ||
22-20555084-G-A | Likely benign (Feb 01, 2023) | |||
22-20564522-C-T | not specified | Likely benign (May 17, 2023) | ||
22-20564529-ACAG-A | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | ||
22-20564581-G-A | not specified | Uncertain significance (Sep 20, 2024) | ||
22-20564609-TGCAGCAGCAGCAGCAGCTCCAGCAGCA-T | Benign (Mar 01, 2023) | |||
22-20564628-CCAG-C | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | ||
22-20564628-C-CCAG | Likely benign (Dec 01, 2022) | |||
22-20566526-ACAG-A | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | ||
22-20566526-ACAGCAGCAG-A | Likely benign (Feb 01, 2023) | |||
22-20566526-A-ACAG | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | ||
22-20566526-A-ACAGCAGCAG | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MED15 | protein_coding | protein_coding | ENST00000263205 | 18 | 91720 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000255 | 125736 | 0 | 12 | 125748 | 0.0000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.53 | 319 | 474 | 0.673 | 0.0000284 | 5141 |
Missense in Polyphen | 46 | 95.771 | 0.48031 | 1064 | ||
Synonymous | -0.678 | 214 | 202 | 1.06 | 0.0000136 | 1532 |
Loss of Function | 5.96 | 7 | 54.5 | 0.128 | 0.00000281 | 480 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000184 | 0.000181 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000354 | 0.0000352 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. Required for cholesterol-dependent gene regulation. Positively regulates the Nodal signaling pathway. {ECO:0000269|PubMed:12167862, ECO:0000269|PubMed:16630888, ECO:0000269|PubMed:16799563}.;
- Pathway
- Sterol Regulatory Element-Binding Proteins (SREBP) signalling;SREBF and miR33 in cholesterol and lipid homeostasis;Developmental Biology;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Transcriptional regulation of white adipocyte differentiation;Regulation of nuclear SMAD2/3 signaling
(Consensus)
Recessive Scores
- pRec
- 0.166
Intolerance Scores
- loftool
- 0.0513
- rvis_EVS
- -1.46
- rvis_percentile_EVS
- 3.78
Haploinsufficiency Scores
- pHI
- 0.730
- hipred
- Y
- hipred_score
- 0.756
- ghis
- 0.625
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 1.00
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Med15
- Phenotype
Zebrafish Information Network
- Gene name
- med15
- Affected structure
- mesendoderm development
- Phenotype tag
- abnormal
- Phenotype quality
- disrupted
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;transcription initiation from RNA polymerase II promoter;stem cell population maintenance
- Cellular component
- nucleus;nucleoplasm;cytoplasm;membrane;mediator complex
- Molecular function
- transcription coregulator activity;protein binding